StatPearls, LLC

  • Atrial Fibrillation
  • Atrial Flutter

Dofetilide

Dofetilide is a class III antiarrhythmic agent primarily used to convert atrial fibrillation or atrial flutter to normal sinus rhythm and maintain sinus rhythm in patients with highly symptomatic atrial fibrillation or atrial flutter lasting longer than a week. This activity reviews the indications, mechanism of action, and contraindications of dofetilide to enhance clinical decision-making for arrhythmic conditions. Other key topics include the drug s adverse event profile, toxicity, dosing considerations, monitoring requirements, and potential drug interactions. The role of the interprofessional healthcare team in managing dofetilide therapy is highlighted, emphasizing collaboration during acute and chronic arrhythmic care. By addressing these areas, this activity supports healthcare professionals in optimizing treatment strategies to improve patient outcomes and elevate care standards for those requiring dofetilide therapy.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 1.5 creditsAAPA Category 1 Credit™Up to 1.5 creditsAMA PRA Category 1 Credit™Up to 1.5 creditsNursingUp to 1.5 creditsPharmacyUp to 1.5 credits

MOC types

ABS — Accredited CMEUp to 1.5 pointsABPATH — Lifelong LearningUp to 1.5 pointsABA — Lifelong LearningUp to 1.5 pointsABTS — Accredited CMEUp to 1.5 pointsABIM — Medical KnowledgeUp to 1.5 pointsABS — Self-AssessmentUp to 1.5 pointsABP — Lifelong Learning and Self-AssessmentUp to 1.5 pointsABTS — Self-AssessmentUp to 1.5 points

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Cross-Specialty

Relevant across 8 specialties.

Pricing

Fee varies

This provider typically $49–98

See fees on statpearls.com

Listed by the provider

  • Article / monograph / reference
  • Credit · Up to 1.5 credits
  • MOC · Up to 1.5 points
  • Fee varies · this provider typically $49–98
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Sep 1, 2029 3 years left